Correlation Between Molecular Partners and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Mink Therapeutics, you can compare the effects of market volatilities on Molecular Partners and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Mink Therapeutics.
Diversification Opportunities for Molecular Partners and Mink Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Molecular and Mink is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and Mink Therapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.81 times more return on investment than Mink Therapeutics. However, Molecular Partners AG is 1.23 times less risky than Mink Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 623.00 in Molecular Partners AG on July 21, 2024 and sell it today you would lose (136.00) from holding Molecular Partners AG or give up 21.83% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Molecular Partners AG vs. Mink Therapeutics
Performance |
Timeline |
Molecular Partners |
Mink Therapeutics |
Molecular Partners and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Molecular Partners and Mink Therapeutics
The main advantage of trading using opposite Molecular Partners and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.Molecular Partners vs. KBC Groep NV | Molecular Partners vs. Pfizer Inc | Molecular Partners vs. JPMorgan Chase Co | Molecular Partners vs. Davis Select Worldwide |
Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |